학술논문
'학술논문'
에서 검색결과 46건 | 목록
1~10
Academic Journal
Dembla, V.; Ray, D.; Lockett, P.; Fullmer, C.; Subramanian, H.; Subbiah, V.; Fu, S.; Janku, F.; Tsimberidou, A.M.; Naing, A.; Piha-Paul, S.A.; Hong, D.S.; Pant, S.; Miller, V.A.; Lim, J.; Le, H.; Karp, D.D.
In European Journal of Cancer December 2016 69 Supplement 1:S138-S139
Academic Journal
Al-Issa, Karam; Visconte, Valeria; Rogers, Heesun J.; Dembla, Vikas; Lichtin, Alan E.; Tiu, Ramon V.
In Blood Cells, Molecules and Diseases March 2015 54(3):281-283
Academic Journal
Dembla V; Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Somaiah N; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Barata P; Department of Solid Tumors, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Hess K; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Fu S; Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Janku F; Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Karp DD; Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Naing A; Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Piha-Paul SA; Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Subbiah V; Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Tsimberidou AM; Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Shaw K; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Meric-Bernstam F; Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Hong DS; Department of Investigational Cancer Therapeutics (Phase 1 Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Academic Journal
Dembla V; Department of Investigational Cancer Therapeutics (Phase 1 Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Groisberg R; Department of Investigational Cancer Therapeutics (Phase 1 Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hess K; Department of Biostatistics,The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fu S; Department of Investigational Cancer Therapeutics (Phase 1 Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wheler J; Novartis, Cambridge, MA, USA.; Hong DS; Department of Investigational Cancer Therapeutics (Phase 1 Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Janku F; Department of Investigational Cancer Therapeutics (Phase 1 Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zinner R; Thomas Jefferson Hospital, Philadelphia, PA, United States.; Piha-Paul SA; Department of Investigational Cancer Therapeutics (Phase 1 Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ravi V; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Benjamin RS; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel S; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Somaiah N; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Herzog CE; Division of Pediatrics,The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Karp DD; Department of Investigational Cancer Therapeutics (Phase 1 Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Roszik J; Department of Melanoma Medical Oncology,The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Meric-Bernstam F; Department of Investigational Cancer Therapeutics (Phase 1 Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Subbiah V; Department of Investigational Cancer Therapeutics (Phase 1 Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. vsubbiah@mdanderson.org.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Report
Dembla V; Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center ; Hematology-Oncology, Overton Brooks VA Medical Center.
Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: Electronic Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Academic Journal
Dembla, V.; Ray, D.; Lockett, R.; Fullmer, C.; Subramanian, H.; Subbiah, V.; Fu, S.; Janku, F.; Tsimberidou, A. M.; Naing, A.; Piha-Paul, S. A.; Hong, D. S.; Pant, S.; Miller, V. A.; Lim, J.; Le, H.; Karp, D. D.
Periodical
검색 결과 제한하기
제한된 항목
[검색어] Dembla, V.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어